APA (7th ed.) Citation

Woyach, J. A., Barr, P. M., Kipps, T. J., Barrientos, J. C., Ahn, I. E., Ghia, P., . . . Burger, J. A. (2023). Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study. Cancers, 15(2), 507. https://doi.org/10.3390/cancers15020507

Chicago Style (17th ed.) Citation

Woyach, Jennifer A., et al. "Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study." Cancers 15, no. 2 (2023): 507. https://doi.org/10.3390/cancers15020507.

MLA (9th ed.) Citation

Woyach, Jennifer A., et al. "Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study." Cancers, vol. 15, no. 2, 2023, p. 507, https://doi.org/10.3390/cancers15020507.